Skip to main content

Post-IPO Equity Life Science Companies

Explore 105 life science startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
105
Total Funding
$2.5B
Avg Funding
$100.2M
Cities
20

Export 105 Post-IPO Equity Life Science Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Palo Alto, United States
$125.0M
raised

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Houston, United States
$11.1M
raised

Coya Therapeutics is a T Reg platform company addressing neurodegenerative, autoimmune, and metabolic diseases

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Singapore, Singapore
$91.1M
raised

Mirxes is an RNA technology company that develops blood-based miRNA test kits for early disease detection.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Calgary, Canada
$886K
raised

Onco-Innovations is a biotech business that develops and commercializes medicines for various cancers.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Richmond, United States
$115.0M
raised

BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 105 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United States
$50.0M
raised

Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$345.1M
raised

Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Carlton South, Australia
$2.9M
raised

Chimeric Therapeutics is a company developing ground-breaking CAR T cell therapies for solid tumors.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Oakville, Canada
$18K
raised

FendX Technologies is a technology company developing surface protection products that protect surfaces from pathogen contamination.

Nov 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$250.0M
raised

Centessa Pharmaceuticals is a pharmaceutical company that focuses on drug development to address significant medical needs.

Nov 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 105 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Toronto, Canada
$325K
raised

Glow LifeTech is a Canadian-based biotechnology company focused on producing nutraceutical and cannabinoid-based products.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$250.0M
raised

Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Berlin, Germany
$149.5M
raised

AtaiBeckley develops innovative mental health treatments that address significant unmet medical needs.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$154.0M
raised

LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Redwood City, United States
$25.0M
raised

Biomea Fusion is a precision oncology company developing novel small molecules that target aggressive forms of cancer.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 105 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
$58.9M
raised

Cypherpunk is a biopharmaceutical company developing antibody therapies for cancer while executing a digital-asset treasury strategy.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Los Altos, United States
$100.0M
raised

Semnur Pharmaceuticals is a specialty pharmaceutical company focusing on clinical and commercial development of innovative products.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$690.0M
raised

Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$20.3M
raised

Liberty Gold is an exploration-stage company that engages in the exploration, production, and development of gold and precious metals.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$5.0M
raised

Prime Medicine is a biotechnology company that utilizes Prime Editing to modify genetic sequences to treat a wide range of diseases.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 105 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Santa Ana, United States
$2.0M
raised

NKGen Biotech is restoring immune function through the development of unique natural killer (NK) cell therapies for the treatment of cancer.

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Guilford, United States
$50.0M
raised

Quantum SI offers Next Generation Protein Sequencing that makes diagnostics digital.

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$438K
raised

Psyence develops natural psilocybin products for the treatment of psychological trauma and mental health disorders

Jun 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Modalis is a biotech company that develops therapeutics using CRISPR based technology.

Jun 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$8.0M
raised

CERo Therapeutics, Inc. is a new cellular immunotherapy company.

Apr 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 51 to 75 of 105 companies

Ready to Connect with Post-IPO Equity Life Science Startups?

Get verified founder emails, funding details, and company data for 105 post-ipo equity life science companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

105 Life Science Post-IPO Equity Startups (November 2026) — Page 3 | VCBacked